You are here: Industry Insights > ICR

News List

ICR unveils efficacious cancer drug with new mechanism of action pharmaceutical-technology
February 13, 2019
Researchers from the Institute of Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust have announced promising results from a phase I/II into tisotumab vedotin (TV) in patients with one of six, drug-resistant cancers....
New cancer drugs taking longer to reach NHS patients pharmatimes
December 06, 2018
A new report by The Institute of Cancer Research (ICR) has found that NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use.
Movember: reducing the adverse effects of testicular cancer treatments pharmaceutical
November 19, 2018
One of the three male-specific health causes focused upon during Movember is testicular cancer. Despite having a 95% survival rate。
Researchers to trial prostate cancer saliva test pharmatimes
July 10, 2018
An international team of researchers, led by scientists at The Institute of Cancer Research, London, are planning to trial a novel saliva-based DNA test designed to predict men at risk of developing prostate cancer.
ICR researchers discover use of ibrutinib drug to attack oesophageal cancer cells pharmaceutical-technology
August 25, 2017
Scientists from the UK Institute of Cancer Research (ICR) have identified an existing drug, ibrutinib, which could be effective against oesophageal cancers.

Previous page 1 2 3 Next page